CellWell record HH-77161
Poly(2-oxazoline)-Based Lipid Nanocapsules Containing Free Hydroxyl Group as Promising Alternative to Conventional PEG-Lipid Nanocapsules
Stéphane Hoang; Tetiana Dumych; Solomiya Paryzhak; Véronique Montembault; Laurent Fontaine; Catherine Passirani; Patrick Saulnier; Oksana Krupka
2026
In plain language
Poly(2-oxazoline) lipid nanocapsules of 63 to 74 nm stayed colloidally stable for a month and showed cytocompatibility comparable to PEG nanocapsules in HeLa, HEK293 and B16F10 cells, with low toxicity in vivo.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-77161
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.